The FOCUS4 programme was designed to identify and register eligible patients, perform a set of molecular tests on a sample of their tumour and then enrol them into a specific randomised trial based on the results of the molecular tests. Each molecularly stratified trial aimed to compare a novel intervention to placebo or standard care. Please follow the links above for detailed information on the trial and click on the 'News' tab above for links to the publications.
The primary research objectives fall into 3 main categories:
Access all the required documentation for site set-up and site closure such as: :
FOCUS4 aimed to register 2400 and randomise at least 1536 patients from over 100 hospitals across the whole of the UK.
FOCUS4 started recruitment in January 2014, and closed to recruitment in October 2020.
There were 94 sites open in the UK that recruited to FOCUS4.
Trial Committees and Investigators
There are a number of committees involved with the oversight of the trial.